Issue 8 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

28

No.

8

August 26, 2005Aug 26, 2005

Free

DOWNLOAD THE PDF

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

Two-Point Rise In PSA Signals High-Risk Prostate Cancer

High Cervical Cancer Rates Indicate Access Problems

Lifestyle Changes Common After Cancer Diagnosis

Proton Beam Radiation Helps Cancer Patients Retain Vision

Cooperative Group Trials Approved By NCI Are Listed

Recent Issues

Volume 52 | Issue 41 - November 06, 2026

Volume 52 | Issue 40 - October 30, 2026

Volume 52 | Issue 39 - October 23, 2026

Volume 52 | Issue 38 - October 16, 2026

Volume 52 | Issue 37 - October 09, 2026

Volume 52 | Issue 36 - October 02, 2026